arrow
Y

Yiwey Shieh

Weill Cornell Medicine
H指数:16
被引数:1,507

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design

WISDOM随机试验比较基于风险与年度乳腺癌筛查:研究队列特征与设计

2026-05-240
OAAI
Neighborhood deprivation on increasing deficit accumulation in older breast cancer survivors and noncancer control individuals

社区剥夺对增加老年乳腺癌幸存者和非癌症对照个体累积赤字的影响

2025-11-220
OAAI
Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial

在WISDOM研究中大规模整合乳腺癌多基因风险评分:一项全国性随机个性化筛查试验

2025-08-300
OAAI
Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women

全外显子组测序鉴定FANCM为西班牙裔/拉丁裔女性雌激素受体阴性乳腺癌的易感基因

2025-08-210
OA
Development and testing of a polygenic risk score for breast cancer aggressiveness
2023-05-154
OA
The WISDOM study: Reducing sequential steps and implementing parallel workflows in pragmatic trials

智慧研究: 在务实试验中减少顺序步骤并实施并行工作流程

2022-02-150
PRE
The impact of streamlined processes and patient-directed messaging to improve enrollment in a remote, pragmatic clinical trial

简化流程和以患者为导向的消息传递对提高远程、务实临床试验入学率的影响

2022-02-150
PRE
The WISDOM study: a new approach to screening can and should be tested

智慧研究: 一种新的筛查方法可以而且应该进行测试

2021-09-1627
OA
Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry

风险阈值升高可预测雅典娜筛查注册表中降低内分泌风险的药物使用

2021-08-033
OAAI
A breast cancer multi-racial/ethnic polygenic risk score for improved personalized breast cancer screening
2020-02-151
PRE